SCRI is a clinical research site located in Nashville, Tennessee, United States 37203.
Crixeo Clinical Trials Trust Score: 19/100 (FAILING). This profile has not yet been claimed by the site owner.
SCRI has participated in 15 clinical trials with 1 currently active.
Therapeutic areas: Multiple Myeloma, Neoplasms, Advanced Solid Tumor and Lymphoma Malignancies.
Sponsors: Celgene, Hoffmann-La Roche, Calithera Biosciences, Inc.
Is this your site? Claim your profile and control the information sponsors and patients see.
Browse all research sites in Tennessee · View every site in Nashville
Trust Score: 19/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.
SCRI has a Crixeo Trust Score of 19/100 (FAILING). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.
SCRI has 15 clinical trials on record, with 1 currently active. Their work covers Multiple Myeloma, Neoplasms, Advanced Solid Tumor and Lymphoma Malignancies.
SCRI has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.
Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.